Companies: 10,795·Total market cap: $144.5T
BioVie Inc.

BioVie Inc.

BIVINASDAQHealthcare● Active
$1.67
+$0.07(+4.38%)
Market Cap$12594871
P/E Ratio—
52W High$12.1
52W Low$1.06
SEC Filings

BioVie Inc. (BIVI) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001580149 · BIVI · NASDAQ · as of Jun 9, 2026

Filing snapshot

481
Total Filings
10-Q
Latest Form
2026-05-11
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001580149 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-08-15
Fiscal Year End
Aug 15, 2025
Accession No.
0001520138-25-000268
Primary Document
bivi-20250630_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001580149 · Accession 0001520138-25-000268

Latest Key Filings

10-QQuarterly Report
FORM 10-Q FOR PERIOD ENDING MARCH 31, 2026
2026-05-11
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2025-11-13Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
FORM 10-Q FOR PERIOD ENDING MARCH 31, 2026
2026-05-11
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-03-25
View
10-QQuarterly Report
FORM 10-Q FOR PERIOD ENDING DECEMBER 31, 2025
2026-02-06
View
S-8Employee Stock Plan Registration
FORM S-8
2025-11-25
View
EFFECTEFFECT
EFFECT
2025-11-18
View
8-KCurrent Report
CURRENT REPORT
2025-11-13
View
8-KCurrent Report
CURRENT REPORT
2025-11-12
View
10-QQuarterly Report
FORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2025
2025-11-10
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2025-10-28
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2025-10-27
View
POS AMPOS AM
POS AM
2025-10-06
View
POS EXPOS EX
POS EX
2025-10-06
View
424B3424B3
424B3 PROSPECTUS SUPPLEMENT NO.1
2025-10-06
View
DEF 14AProxy Statement
DEF 14A
2025-09-25
View
10-KAnnual Report
FORM 10-K
2025-08-15
View
Showing 1–15 of 369 filingsForm 4 / 144 hidden· 481 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001580149  |  Exchange: NASDAQ · Healthcare

BioVie Inc. (NASDAQ: BIVI) has submitted 481 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001580149, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is BioVie Inc.'s most comprehensive regulatory disclosure. The most recent BioVie Inc. 10-K was filed on 2025-08-15 for fiscal year ending 2025. Historical BIVI 10-K annual reports are available from 2013 through 2025.

Investors researching BioVie Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
KZIA SEC Filings →TOVX SEC Filings →ARTL SEC Filings →ELAB SEC Filings →INM SEC Filings →CANF SEC Filings →GLMD SEC Filings →LIPO SEC Filings →
→ BIVI Financials→ BIVI Earnings→ BIVI Insider Trades

Frequently Asked Questions

BIVI SEC Filings · 8 questions

BioVie Inc. (BIVI) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 481 filings and access original documents at no cost. BioVie Inc.'s CIK is 0001580149.

BIVI SEC filingsBioVie Inc. SEC documentsfind BIVI 10-K